518 related articles for article (PubMed ID: 27241179)
21. Molecular Mechanisms Underlying Curcumin-Mediated Therapeutic Effects in Type 2 Diabetes and Cancer.
Wojcik M; Krawczyk M; Wojcik P; Cypryk K; Wozniak LA
Oxid Med Cell Longev; 2018; 2018():9698258. PubMed ID: 29743988
[TBL] [Abstract][Full Text] [Related]
22. Curcumin: the Indian solid gold.
Aggarwal BB; Sundaram C; Malani N; Ichikawa H
Adv Exp Med Biol; 2007; 595():1-75. PubMed ID: 17569205
[TBL] [Abstract][Full Text] [Related]
23. The beneficial role of curcumin on inflammation, diabetes and neurodegenerative disease: A recent update.
Ghosh S; Banerjee S; Sil PC
Food Chem Toxicol; 2015 Sep; 83():111-24. PubMed ID: 26066364
[TBL] [Abstract][Full Text] [Related]
24. Curcumin, a component of turmeric: from farm to pharmacy.
Gupta SC; Kismali G; Aggarwal BB
Biofactors; 2013; 39(1):2-13. PubMed ID: 23339055
[TBL] [Abstract][Full Text] [Related]
25. Therapeutic effects of curcumin on sepsis and mechanisms of action: A systematic review of preclinical studies.
Karimi A; Ghodsi R; Kooshki F; Karimi M; Asghariazar V; Tarighat-Esfanjani A
Phytother Res; 2019 Nov; 33(11):2798-2820. PubMed ID: 31429161
[TBL] [Abstract][Full Text] [Related]
26. Biological properties of metal complexes of curcumin.
Shakeri A; Panahi Y; Johnston TP; Sahebkar A
Biofactors; 2019 May; 45(3):304-317. PubMed ID: 31018024
[TBL] [Abstract][Full Text] [Related]
27. Curcumin, Cardiometabolic Health and Dementia.
Kim Y; Clifton P
Int J Environ Res Public Health; 2018 Sep; 15(10):. PubMed ID: 30250013
[TBL] [Abstract][Full Text] [Related]
28. Curcumin-free turmeric exhibits anti-inflammatory and anticancer activities: Identification of novel components of turmeric.
Aggarwal BB; Yuan W; Li S; Gupta SC
Mol Nutr Food Res; 2013 Sep; 57(9):1529-42. PubMed ID: 23847105
[TBL] [Abstract][Full Text] [Related]
29. Why it is necessary to translate curcumin into clinical practice for the prevention and treatment of metabolic syndrome?
Sahebkar A
Biofactors; 2013; 39(2):197-208. PubMed ID: 23239418
[TBL] [Abstract][Full Text] [Related]
30. Curcumin ameliorates cisplatin-induced nephrotoxicity by inhibiting renal inflammation in mice.
Ueki M; Ueno M; Morishita J; Maekawa N
J Biosci Bioeng; 2013 May; 115(5):547-51. PubMed ID: 23245727
[TBL] [Abstract][Full Text] [Related]
31. Curcumin and Lung Cancer: the Role of microRNAs.
Lelli D; Pedone C; Majeed M; Sahebkar A
Curr Pharm Des; 2017; 23(23):3440-3444. PubMed ID: 28067164
[TBL] [Abstract][Full Text] [Related]
32. Curcumin inhibits HMGB1 releasing and attenuates concanavalin A-induced hepatitis in mice.
Wang C; Nie H; Li K; Zhang YX; Yang F; Li CB; Wang CF; Gong Q
Eur J Pharmacol; 2012 Dec; 697(1-3):152-7. PubMed ID: 23063543
[TBL] [Abstract][Full Text] [Related]
33. Development of curcumin as an epigenetic agent.
Fu S; Kurzrock R
Cancer; 2010 Oct; 116(20):4670-6. PubMed ID: 20597137
[TBL] [Abstract][Full Text] [Related]
34. Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research.
Jurenka JS
Altern Med Rev; 2009 Jun; 14(2):141-53. PubMed ID: 19594223
[TBL] [Abstract][Full Text] [Related]
35. Curcumin, autoimmune and inflammatory diseases: going beyond conventional therapy - a systematic review.
Marton LT; Barbalho SM; Sloan KP; Sloan LA; Goulart RA; Araújo AC; Bechara MD
Crit Rev Food Sci Nutr; 2022; 62(8):2140-2157. PubMed ID: 33938775
[TBL] [Abstract][Full Text] [Related]
36. Antidiabetic Properties of Curcumin: Insights on New Mechanisms.
Mohammadi E; Behnam B; Mohammadinejad R; Guest PC; Simental-Mendía LE; Sahebkar A
Adv Exp Med Biol; 2021; 1291():151-164. PubMed ID: 34331689
[TBL] [Abstract][Full Text] [Related]
37. Curcumin as a potential therapeutic candidate for Helicobacter pylori associated diseases.
Sarkar A; De R; Mukhopadhyay AK
World J Gastroenterol; 2016 Mar; 22(9):2736-48. PubMed ID: 26973412
[TBL] [Abstract][Full Text] [Related]
38. Molecular mechanisms underlying chemopreventive potential of curcumin: Current challenges and future perspectives.
Kumar G; Mittal S; Sak K; Tuli HS
Life Sci; 2016 Mar; 148():313-28. PubMed ID: 26876915
[TBL] [Abstract][Full Text] [Related]
39. Curcumin and liver cancer: a review.
Darvesh AS; Aggarwal BB; Bishayee A
Curr Pharm Biotechnol; 2012 Jan; 13(1):218-28. PubMed ID: 21466422
[TBL] [Abstract][Full Text] [Related]
40. Curcumin in depressive disorders: An overview of potential mechanisms, preclinical and clinical findings.
Kaufmann FN; Gazal M; Bastos CR; Kaster MP; Ghisleni G
Eur J Pharmacol; 2016 Aug; 784():192-8. PubMed ID: 27235294
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
